Article
Monoclonal antibody 1.6.1 against human MPL receptor allows HSC enrichment of CB and BM CD34(+)CD38(-) populations.
Experimental hematology - 1 Apr 2016
Petit Cocault Laurence, Fleury Maud, Clay Denis, Larghero Jérôme, Vanneaux Valérie, Souyri Michèle
Abstract excerpt
Thrombopoietin (TPO) and its receptor Mpl (CD110) play a crucial role in the regulation of hematopoietic stem cells (HSCs). Functional study of Mpl-expressing HSCs has, however, been hampered by the lack of efficient monoclonal antibodies, explaining the very few data available on Mpl(+) HSCs during human embryonic development and after birth. Investigating the main monoclonal antibodies used so far to sort...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
